Akt-dependent phosphorylation of hepatic Foxo1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity

Diabetes

Volumn 63, Issue 8, 2014, Pages 2690-2701

  Sajan, Mini P ^a,b   Acevedo Duncan, Mildred E ^a,b   Standaert, Mary L ^a,b   Ivey, Robert A ^a,b   Lee, Mackenzie ^a,b   Farese, Robert V ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL FEED; ANIMALS; CARRIER PROTEINS; CERAMIDES; DIET, HIGH-FAT; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; INSULIN; LIVER; MALE; MICE; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84905004481     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1863     Document Type: Article

References (28)

1. Farese RV, Sajan MP Metabolic functions of atypical protein kinase C: "good" and "bad" as defined by nutritional status. Am J Physiol Endocrinol Metab 2010; 298:E385-E394
2. Sajan MP, Farese RV Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-i (PKC-i) and dependent processes and reversal by PKC-i inhibitors. Diabetologia 2012; 55: 1446-1457
3. Standaert ML, Sajan MP, Miura A, et al Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem 2004; 279:24929-24934
4. Sajan MP, Standaert ML, Rivas J, et al Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance. Diabetologia 2009; 52: 1197-1207
5. Sajan MP, Nimal S, Mastorides S., et al. Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-i. Metabolism 2012; 61:459-469
6. Sajan MP, Standaert ML, Nimal S, et al The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity. J Lipid Res 2009; 50:1133-1145
7. Yang G, Badeanlou L, Bielawski J., Roberts AJ, Hannun YA, Samad F. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2009; 297:E211-E224
8. Ussher JR, Koves TR, Cadete V.J., et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010; 59:2453-2464
9. Bikman BT, Summers SA Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 2011; 121:4222-4230
10. Li S, Brown MS, Goldstein JL Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of glu-coneogenesis. Proc Natl Acad Sci U S A 2010; 107:3441-3446
11. Kitamura Y, Accili D. New insights into the integrated physiology of insulin action. Rev Endocr Metab Disord 2004; 5:143-149
12. Matsumoto M, Pocai A, Rossetti L., Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 2007; 6:208-216
13. Fritzius T, Burkard G, Haas E., et al. A WD-FYVE protein binds to the kinases Akt and PKCzeta/l. Biochem J 2006; 399:9-20
14. Fritzius T, Moelling K. Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis. EMBO J 2008; 27:1399-1410
15. Sajan MP, Ivey RA 3rd, Farese RV. Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression. Diabetologia 2013; 56:2507-2516
16. Farese RV, Sajan MP, Yang H, et al Muscle-specific knockout of PKC-l impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest 2007; 117:2289-2301
17. Guo S, Copps KD, Dong X, et al The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol 2009; 29:5070-5083
18. Matsumoto M, Ogawa W, Akimoto K., et al. PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest 2003; 112:935-944
19. Taniguchi CM, Kondo T, Sajan M.P., et al. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/z. Cell Metab 2006; 3:343-353
20. Wang G, Silva J, Krishnamurthy K., Tran E, Condie BG, Bieberich E. Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem 2005; 280:26415-26424
21. Müller G., Ayoub M, Storz P., Rennecke J, Fabbro D, Pfizenmaier K. PKC z is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14:1961-1969
22. Standaert ML, Bandyopadhyay G, Perez L., et al. Insulin activates protein kinases C-ζ and C-λ by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem 1999; 274:25308-25316
23. Khamzina L, Veilleux A, Bergeron S., Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005; 146:1473-1481
24. Liu H-Y, Hung T., Wen, G-B, et al. Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. Am J Physiol Metab 2009; 297:E898-E906
25. Fritzius T, Frey AD, Schweneker M, Mayer D., Moelling K. WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Czeta. FEBS J 2007; 274:1552-1566
26. Konishi H, Kuroda S, Kikkawa U. The pleckstrin homology domain of RAC protein kinase associates with the regulatory domain of protein kinase C z. Bi-ochem Biophys Res Commun 1994; 205:1770-1775
27. Doornbos RP, Theelen M, van der Hoeven PC, van Blitterswijk WJ, Verkleij AJ, van Bergen en Henegouwen PM. Protein kinase Czeta is a negative regulator of protein kinase B activity. J Biol Chem 1999; 274:8589-8596
28. Weyrich P, Neuscheler D, Melzer M., Hennige AM, Häring HU, Lammers R. The Par6alpha/aPKC complex regulates Akt1 activity by phosphorylating Thr34 in the PH-domain. Mol Cell Endocrinol 2007; 268:30-36